Amply Power offers a charging-as-a-service model that enables commercial fleet operators to transition to electric vehicles by providing tailored EV charging solutions. This approach addresses the challenge of managing charging infrastructure and costs, ensuring efficient fleet operations while supporting sustainability goals.

Atriva Therapeutics develops first-in-class host-targeting therapies, specifically zapnometinib, to treat severe viral infections such as influenza and COVID-19 by modulating the host's immune response. The company addresses the need for effective antiviral treatments in the face of emerging respiratory viruses, with promising results from completed Phase I and Phase II clinical trials.

E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.

Flybotix designs a collision-tolerant drone equipped with advanced navigation and obstacle avoidance systems for in-structure and indoor inspections. This technology enables efficient inspections of hard-to-reach areas in buildings, significantly reducing the need for scaffolding and minimizing inspection time.

The startup provides high-speed internet services through fiber optic and digital subscriber line technologies, ensuring users can access the internet securely and privately. By prioritizing user privacy and online safety, the company addresses the growing concerns over data security in digital communications.

Hemispherian develops a novel class of small molecule drugs that target the TET2 enzyme to treat aggressive cancers, with a focus on glioblastoma. By restoring the normal epigenetic state of cancer cells, these therapeutics induce DNA damage response and promote cancer cell death while minimizing harm to normal tissues.

JXSENS designs and manufactures bespoke inertial sensors and systems utilizing MEMS technology for high-temperature applications in the energy sector and commercial markets. Their solutions address complex navigation and attitude control challenges in diverse environments, including land, sea, air, and space.

Labs develops human-enhancement technologies that utilize artificial intelligence, immersive realities, and consumer-wearables to foster community engagement and improve individual capabilities. The company addresses the need for interconnected social experiences and sustainable practices by providing tools that empower users to learn, create, and collaborate effectively.

LightOx is developing a light-activated chemotherapy treatment using photosensitizing agents to target early-stage oral cancer lesions, which allows for localized therapy with reduced side effects compared to traditional surgical methods. The company is currently completing pre-clinical testing and plans to initiate Phase I/IIa clinical trials in 2025.

Loop Robots provides the SAM robot for automated surface disinfection using germicidal UV-C technology in dynamic environments. This solution targets hospitals, hospital pharmacies, and GMP cleanrooms to enhance safety and efficiency. The system autonomously maps spaces and calculates optimal disinfection trajectories, reducing chemical use and labor requirements.

Moveshelf provides a secure information system for movement analysis that centralizes and stores clinical gait data in the cloud, allowing healthcare professionals to access and visualize patient movement metrics from any location. This platform enhances data management and workflow efficiency, enabling clinicians to integrate movement analysis seamlessly into electronic health records.

Nostics provides a handheld diagnostic platform that uses Raman spectroscopy and AI‑driven Large Spectral Foundation Models to identify bacteria and fungi directly from patient samples in under ten minutes. The portable, cartridge‑based system delivers lab‑comparable, species‑level results at the point of care without requiring laboratory expertise, enabling immediate, data‑driven treatment decisions.

Ola is a finance super app designed specifically for US Hispanics and Latinxs, providing tools for investment, savings, and financial planning. By addressing the significant gap in stock and cryptocurrency ownership among Latinx individuals, Ola empowers users to create personalized financial strategies and access high-yield investment accounts.

Optic is an open-source tool that integrates with IDEs to provide OpenAPI linting, diffing, and testing capabilities. It helps teams prevent breaking changes and ensures accurate API documentation, enhancing the overall design and reliability of their APIs.

Protix transforms organic waste into sustainable insect-based protein and lipid ingredients for animal feed and plant care. Their proprietary technology efficiently converts waste streams into high-value, low-footprint alternatives, reducing reliance on conventional, resource-intensive inputs.

Ro operates a telehealth platform that provides online clinics for weight loss, sexual health, hair restoration, and fertility management using clinically proven treatments and prescription medications. The service eliminates the need for insurance and offers free, discreet shipping, making healthcare accessible and convenient for over 2 million members.

SenseGlove develops haptic gloves that utilize active contact feedback, force feedback, and vibrotactile feedback technologies to provide realistic tactile sensations in virtual reality environments. This enables users to interact with virtual objects naturally, enhancing training and prototyping experiences by allowing them to feel size, stiffness, and resistance, which traditional controllers cannot replicate.

Sword utilizes AI-driven digital physical therapy and personalized care programs to provide accessible treatment for musculoskeletal pain and pelvic health issues. By integrating real-time feedback from physical therapists and AI specialists, Sword aims to reduce the need for costly surgeries and improve overall member health outcomes.